New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

JDOCvsPBPHETF Comparison

ETF 1
JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of
Global Blended Cap
-0.87%
Full JDOC fund page
VS
ETF 2
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
-0.98%
Full PBPH fund page

JPMorgan Healthcare Leaders ETF (JDOC) belongs to the Global Blended Cap segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. JDOC's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, PBPH's top sector exposures are Health Care and Consumer Staples. JDOC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.13% for PBPH. JDOC is down -4.05% year-to-date (YTD) with - in YTD flows. PBPH performs better with 2.99% YTD performance, and +$734M in YTD flows. Run a side-by-side ETF comparison of JDOC and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

JDOC vs PBPH performance and flow charts

Performance

-6.0-4.0-2.00.02.0%Feb 11Feb 19Feb 26Mar 5Mar 12

Cumulative Flows

0 M100 M200 M300 M400 M500 M600 M700 MFeb 11Feb 19Feb 26Mar 5Mar 12

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/13/2026
1M3MYTD1Y3Y5Y
Perf.
JDOC
PBPH
-5.93%-3.01%
-4.12%+5.10%
-4.05%+2.99%
+6.14%n/a
n/an/a
n/an/a
Flows
JDOC
PBPH
-+$689M
-+$734M
-+$734M
-$85K-
--
--
Volatility and drawdown
3M1Y3Y5Y
Volatility
JDOC
PBPH
+13.07%+15.14%
+16.33%n/a
n/an/a
n/an/a
Max drawdown
JDOC
PBPH
-7.03%-5.29%
-11.54%n/a
n/an/a
n/an/a
Max drawdown duration
JDOC
PBPH
50d22d
192dn/a
n/an/a
n/an/a
Trading data

Create an account to view trading data

Join for free
JDOC
PBPH
Last sale
3/13/2026 at 1:30 PM
$55.49
$25.47
Previous close
03/12/2026
$55.86
$25.61
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

JDOC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
JDOC
PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
JDOC
PBPH
Last price
$55.49
$25.47
1D performance
-0.65%
-0.55%
AuM$8.33 M$714.23 M
E/R0.65%0.13%
Characteristics
JDOC
PBPH
Management strategyActivePassive
ProviderJ.P. Morgan Asset ManagementTidal
Benchmark-BITA Global Pharma and Biotech Select Index
N° of holdings5346
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2023November 24, 2025
ESGNoNo
Advertisement
Exposure

Countries

JDOC
USA
67.95%
Other
32.05%
PBPH
USA
62%
Switzerland
11.74%
Other
26.26%

Sectors

JDOC
Health Care
90.99%
Other
9.01%
PBPH
Health Care
88%
Other
12%
Advertisement

Diversification

JDOC

Total weight of top 15 holdings out of 15

57.94%
PBPH

Total weight of top 15 holdings out of 15

73.19%

Top 15 holdings

Data as of January 31, 2026
JDOC
JOHNSON&JOHNSON
7.29%
LILLY
7.16%
ABBVIE
5.40%
MERCK & CO INC
4.97%
ASTRAZENECA
4.83%
DK0062498333
3.86%
UNITEDHEALTH GRP
3.41%
DANAHER
3.38%
MEDTRONIC PLC
3.01%
ROCHE
2.91%
BRISTOL-MYERS SQUIBB
2.44%
ARGEN X NV
2.41%
BOSTON SCIENTIFIC
2.41%
CVS HEALTH CORP
2.30%
REGENERON PHARMACEUTICALS
2.16%
PBPH
LILLY
14.67%
JOHNSON&JOHNSON
9.05%
ABBVIE
6.50%
ROCHE
5.25%
NOVARTIS
4.96%
MERCK & CO INC
4.69%
DK0062498333
4.35%
AMGEN-T
4.30%
GILEAD SCIENCES
4.08%
PFIZER
3.46%
VERTEX PHARMACEUTICALS
2.72%
BRISTOL-MYERS SQUIBB
2.59%
SANOFI SA
2.49%
GSK PLC
2.36%
REGENERON PHARMACEUTICALS
1.71%
Frequently asked questions about JDOC and PBPH

How have the JDOC and PBPH ETFs performed in 2026?

As of March 13, 2026, JDOC is down -4.05% year-to-date (YTD), while PBPH has returned 2.99%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: JDOC or PBPH?

Year-to-date, the JDOC ETF saw - in flows, compared to +$734M for PBPH.

Which ETF is bigger: JDOC or PBPH?

As of March 13, 2026, JDOC holds $8.33 M in assets under management (AUM), while PBPH manages $714.23 M.

What sectors do the JDOC and PBPH ETFs invest in?

JDOC leans toward sectors like Health Care. Meanwhile, PBPH focuses on Health Care.

What are the top holdings of the JDOC ETF and PBPH ETF?

JDOC top holdings include JOHNSON&JOHNSON, LILLY and ABBVIE. PBPH holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: JDOC or PBPH?

JDOC holds 58 securities with 57.94% of its assets in the top 15. PBPH has 49 securities and a top 15 weight of 73.19%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast